2026 Annual Meeting | H30 - Brazilian Jiu-jitsu (Wellness Hub)
Date
Saturday 04/18/26
Time
02:15 PM - 03:00 PM CDT
Add To Calendar
Location
McCormick Place West | W375e Lobby
Session Format
This program will be presented in-person only
On Demand
This program is not expected to be available in the meeting's On Demand product.
Event Type
Hubs (Wellness)
Director(s)
Rodolfo Savica, MD, PhD, FAAN, Meriem K. Bensalem Owen, MD
Topic(s)
General Neurology
Learning Objectives
Step off the conference floor and onto the mat for an energizing Brazilian Jiu-Jitsu (BJJ) session. Led by experienced instructors, this interactive workshop blends movement, strategy, and mindset to help you recharge while learning practical skills. Participants should explore the fundamentals of leverage, balance, and controlled movement, as well as principles that translate seamlessly from the mat to the workplace. Through partner drills and guided techniques, you’ll experience how BJJ sharpens focus, builds confidence, and enhances problem-solving under pressure.
CME Available
No CME available
Core Competencies
Interpersonal and Communication Skills
Program Level
Introductory
Recommended Audience
Fellow, Resident, Other, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider, Neurohospitalist, Medical Student, Business Administrator, Coordinator
Teaching Styles
Other
Program Materials
Program Evaluations
Event Timeline
02:15 PM - 03:00 PM CDT
Speaker
Brazilian Jiu-jitsu
Rodolfo Savica, MD, PhD, FAAN, Meriem K. Bensalem Owen, MD
Faculty Disclosures
Meriem K. Bensalem Owen, MD
Dr. Bensalem Owen has received personal compensation in the range of $0-$499 for serving as a Principle Investigator (PI) with Xenon. Dr. Bensalem Owen has received personal compensation in the range of $0-$499 for serving as a PI with UCB. Dr. Bensalem Owen has received personal compensation in the range of $0-$499 for serving as a PI with NeuroPace.
Rodolfo Savica, MD, PhD, FAAN
The institution of Dr. Savica has received research support from ACADIA Pharmaceuticals, Inc.